Iron supplementation of young children: learning from the new evidence

Rebecca J Stoltzfus1, Rebecca Heidkamp, Donald Kenkel

  • 1Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA. rjs62@cornell.edu

Food and Nutrition Bulletin
|February 27, 2008
PubMed

Insights

Iron deficiency is common in early childhood. New evidence suggests targeted iron supplementation may benefit deficient children without increasing risks, but more research is needed.

Area of Science:

  • Pediatric Nutrition
  • Micronutrient Supplementation
  • Global Public Health

Background:

  • Early childhood is a high-risk period for iron deficiency due to high iron needs and low-iron diets.
  • Current iron supplementation recommendations are based on benefits for anemia and child development, but evidence on growth and morbidity is mixed.
  • New evidence from Nepal and Zanzibar warrants a review of iron supplementation strategies.

Purpose of the Study:

  • To review new evidence on iron supplementation in early childhood from Nepal and Zanzibar.
  • To discuss interpretations of growth and morbidity outcomes.
  • To explore cost-effectiveness and targeted supplementation strategies.

Main Methods:

  • Review of new evidence from trials in Nepal and Zanzibar.
  • Analysis of growth and morbidity outcomes.
  • Cost-effectiveness analysis of supplementation strategies.

Main Results:

  • The Zanzibar trial showed adverse effects in the general population but significant benefits for iron-deficient children.
  • Targeting supplements to iron-deficient children in Zanzibar may be cost-effective and increase benefits.
  • Evidence regarding growth and morbidity from iron supplementation remains equivocal.

Conclusions:

  • Targeted iron supplementation for deficient children in high-risk areas may be a viable strategy.
  • Operations research is needed to test targeted supplementation approaches.
  • Three options are proposed to maximize benefits and minimize risks of iron supplements in early childhood.

Related Concept Videos

Microbes and Other Elemental Cycles01:24

Microbes and Other Elemental Cycles

Microbial activity plays a pivotal role in the biogeochemical cycling of iron and manganese, especially at the redox gradients characteristic of stratified aquatic environments. These cycles are driven by microbial transformations between oxidized and reduced forms of the metals, allowing organisms to exploit them for metabolic energy and structural purposes.Iron Cycling Across Redox GradientsIn neutral, oxygen-rich surface waters, iron is predominantly found in its oxidized, insoluble ferric...
The Periodic Table and Organismal Elements01:27

The Periodic Table and Organismal Elements

Elements are the smallest units of matter that cannot be broken down further by chemical processes. There are 118 known elements, but not all of these are naturally occurring, and only a few of them are essential for life. Living matter is composed primarily of carbon, nitrogen, hydrogen, and oxygen, with smaller amounts of other elements like calcium, phosphorus, potassium, and sulfur. Other elements are also necessary for life but only in trace amounts.
Periodic Table Provides Information...
The Periodic Table and Organismal Elements00:57

The Periodic Table and Organismal Elements

Elements are the smallest units of matter that cannot be broken down further by chemical processes. There are 118 known elements, but not all of these are naturally-occurring, and fewer still are essential for life. Living matter is composed primarily of carbon, nitrogen, hydrogen, and oxygen, with smaller amounts of other elements like calcium, phosphorus, potassium, and sulfur. Other elements are also necessary for life but only in trace amounts.The Periodic Table Provides Information about...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...